However, there was a significant difference in UGT1A1 mRNA in postmenopausal women breast cancer cases compared to controls (Tumor: 0.3 ± 0.2; Normal: 2.2 ± 1.9, p = 0.04) (Figure 2B). This evidence concerns the gene UGT1A1 and breast carcinoma.